Office by Alex Penny
Roger T. Adler, MD, is one of nine physicians comprising the staff of Eye Specialists of Ohio, which offers convenient access for patients at eight locations in the southern part of the state. Dr. Adler, a Clinical Ophthalmologist who trained at Maimonides Medical Center in Brooklyn, New York, and Case Western Reserve University in Cleveland, Ohio, focuses on the diagnosis and treatment of retinal detachment, macular degeneration, ocular inflammation, diabetic retinopathy, and other serious conditions. Dr. Roger T. Adler and his fellow professionals strive to offer the highest quality of patient care possible.
Dr. Roger T. Adler earned his medical degree from Chicago Medical School, one of the graduate institutions associated with the Rosalind Franklin University of Medicine and Science. After completing his internship and residency at Maimonides and Case Western, respectively, he moved to Georgia to assist in treating patients at Eye Consultants of Atlanta.
Dr. Adler holds memberships in the American Society of Retina Specialists, which has more members than any other professional retinal organization in the world. He also belongs to the American College of Eye Surgeons, which promotes enhanced quality of care for all eye patients; the American Academy of Ophthalmology, whose medical and osteopathic professionals work to educate the public about ophthalmic health and disease prevention; and the American Medical Association.
Dr. Roger T. Adler and his colleagues at Eye Specialists of Ohio offer dozens of preventive, diagnostic, and therapeutic procedures, including no-patch, no-stitch, no-shot cataract surgery; wavefront LASIK and other outpatient laser procedures; surgery involving cornea transplants; and Botox injections for medical and cosmetic treatments. Roger T. Adler, MD, is available for consultation by calling (740) 477-7200. Visit "
EyeSpecialistsofOhio.com for additional locations.
The Diabetic Patient with No Visual Complaints
Roger T. Adler, M.D., A.S.R.S.*
This abbreviated synopsis is intended for all medical personnel involved in the caring for patients with Diabetes Mellitus (DM) and not just involved in the patient’s glucose control directly. Examples of such health care providers may include anyone from chiropractors to podiatrists. We all know that diabetes affects the retina. The main question that will be answered in this summary is “When should a diabetic patient have a retinal evaluation?” The key point and take home message is to not wait for your patient to have visual complaints.
EXCELLENT “VISION” DOES NOT NECESSARILY IMPLY HEALTHY EYES!
Diabetic patients may indeed have superb subjective vision even with a very abnormal retina which may lead to permanent vision loss if left untreated. Unfortunately, in the United States of America a significant percent of people who are “newly” diagnosed with diabetes have in fact had diabetes for some time, perhaps years. The prevalence of diabetes is rising in the U.S. Factors that contribute are increasing life span, lifestyle, and awareness of the disease and an increase in screening to mention a few.
When should a diabetic patient have a retinal evaluation?
If the “newly” diagnosed patient is fortunate enough to have no visual complaints, a retinal evaluation and potential treatment to the retina may certainly be indicated TO STATISTICALLY HELP PRESERVE THE VISION THAT THE PATIENT CURRENTLY ENJOYS (ETDRS Study). Although there are many studies related to diabetic eye disease two in particular deserve mention here: The Diabetic Retinopathy Study (DRS) and the already mentioned Early Treatment Diabetic Retinopathy Study (ETDRS). One major conclusion of the ETDRS has proven the beneficial affects of treatment to macular edema regardless of visual acuity. The basis of such is to significantly decrease the “…incidence of moderate visual loss by approximately 50% at all time points…”
One of the major conclusions of the DRS is to treat diabetic patients who have either bled into their eye (vitreous hemorrhage) or at “high-risk” for this event. Treatment is indicated AND recommended for these “high-risk” patients even if when there are no complaints of visual loss or subjective ocular complaints.
“…The DRS findings strongly indicated that prompt scatter photocoagulation should be performed in eyes with high-risk proliferative diabetic retinopathy because of the high risk of severe visual loss without photocoagulation. The DRS photocoagulation treatment protocol effectively reduced the risk of severe visual loss by greater than 50%…”
*A.S.R.S. Member of the American Society of Retina Specialists
by9:
Poster for a Private Party // Carrots Group
Submitted by francescovetica
Dr. Roger T Adler on Xing
Dr. Roger T Adler on Slideshare
Dr. Roger T Adler on Emurse
Dr. Roger T Adler’s Website
Metropolis 1920 Font by Josip Kelava
